| First Author | De Paoli M | Year | 2022 |
| Journal | Am J Physiol Endocrinol Metab | Volume | 323 |
| Issue | 3 | Pages | E254-E266 |
| PubMed ID | 35830687 | Mgi Jnum | J:338947 |
| Mgi Id | MGI:7411090 | Doi | 10.1152/ajpendo.00353.2021 |
| Citation | De Paoli M, et al. (2022) Investigating the protective effects of estrogen on beta-cell health and the progression of hyperglycemia-induced atherosclerosis. Am J Physiol Endocrinol Metab 323(3):E254-E266 |
| abstractText | Sex differences in the prevalence and development of diabetes and associated cardiometabolic complications are well established. The objective of this study was to analyze the effects of estrogen on the maintenance of beta-cell health/function and atherosclerosis progression, using a mouse model of hyperglycemia-induced atherosclerosis, the ApoE(-/-):Ins2(+/Akita) mouse. ApoE(-/-):Ins2(+/Akita) mice exhibit sexual dimorphism in the control of blood glucose levels. Male ApoE(-/-):Ins2(+/Akita) mice are chronically hyperglycemic due to a significant reduction in pancreatic beta-cell mass. Female mice are only transiently hyperglycemic, maintain beta-cell mass, and blood glucose levels normalize at 35 +/- 1 days of age. To determine the effects of estrogen on pancreatic beta-cell health and function, ovariectomies and estrogen supplementation experiments were performed, and pancreatic health and atherosclerosis were assessed at various time points. Ovariectomized ApoE(-/-):Ins2(+/Akita) mice developed chronic hyperglycemia with significantly reduced beta-cell mass. To determine whether the observed effects on ovariectomized ApoE(-/-):Ins2(+/Akita) mice were due to a lack of estrogens, slow-releasing estradiol pellets were inserted subcutaneously. Ovariectomized ApoE(-/-):Ins2(+/Akita) mice treated with exogenous estradiol showed normalized blood glucose levels and maintained beta-cell mass. Exogenous estradiol significantly reduced atherosclerosis in both ovariectomized female and male ApoE(-/-):Ins2(+/Akita) mice relative to controls. Together, these findings suggest that estradiol confers significant protection to pancreatic beta-cell health and can directly and indirectly slow the progression of atherosclerosis.NEW & NOTEWORTHY This study examines the effect(s) of estrogen on beta cell and cardiometabolic health/function in a novel mouse model of hyperglycemia-induced atherosclerosis (ApoE(-/-):Ins2(+/Akita)). Using a combination of estrogen deprivation (ovariectomy) and supplementation strategies, we quantify effects on glucose homeostasis and atherogenesis. Our results clearly show a protective role for estrogen on pancreatic beta-cell health and function and glucose homeostasis. Furthermore, estrogen supplementation dramatically reduces atherosclerosis progression in both male and female mice. |
